Showing 1 - 10 of 188
Persistent link: https://www.econbiz.de/10001813609
Persistent link: https://www.econbiz.de/10001828723
Persistent link: https://www.econbiz.de/10001788624
In dose-response studies, the dose range is often restricted due to ethics concerns over drug toxicity and/or efficacy, particularly when human subjects are involved. We present locally optimal designs for the estimation of several percentiles simultaneously on restricted as well as unrestricted...
Persistent link: https://www.econbiz.de/10002570188
Persistent link: https://www.econbiz.de/10002134018
Persistent link: https://www.econbiz.de/10002141544
In dose-response studies, the dose range is often restricted due to concerns over drug toxicity and/or efficacy. We derive optimal designs for estimating the underlying dose-response curve for a restricted or unrestricted dose range with respect to a broad class of optimality criteria. The...
Persistent link: https://www.econbiz.de/10002755513
Persistent link: https://www.econbiz.de/10001916065
In a recent paper Gonzalez Manteiga and Vilar Fernandez (1995) considered the problem of testing linearity of a regression under MA structure of the errors using a weighted L1-distance between a parametric and a nonparametric fit. They established asymptotic normality of the corresponding test...
Persistent link: https://www.econbiz.de/10009783008
For the problem of checking linearity in a heteroscedastic nonparametric regression model under a fixed design assumption we study maximin designs which maximize the minimum power of a nonparametric test over a broad class of alternatives from the assumed linear regression model. It is...
Persistent link: https://www.econbiz.de/10009783009